Recalls / Class II
Class IID-1877-2019
Product
Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
- Affected lot / code info
- Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021
Why it was recalled
Failed Impurities/Degradation Specifications
Recalling firm
- Firm
- Preferred Pharmaceuticals, Inc
- Notification channel
- Telephone
- Type
- Voluntary: Firm initiated
- Address
- 1250 N Lakeview Ave Ste O, Anaheim, California 92807-1801
Distribution
- Quantity
- 79 (90 ct.) bottles
- Distribution pattern
- Product was distributed to 1 physician in Gainesville Florida.
Timeline
- Recall initiated
- 2019-08-29
- FDA classified
- 2019-09-24
- Posted by FDA
- 2019-10-02
- Terminated
- 2023-04-24
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1877-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.